Mesenchymal Stem Cells in Fibrotic Disease
Elie El Agha1, Rafael Kramann2, Rebekka K Schneider3
1Institute of Life Sciences, Wenzhou University, Wenzhou University-Wenzhou Medical University Collaborative Innovation Center of Biomedicine, Wenzhou, Zhejiang, China; Excellence Cluster Cardio-Pulmonary System (ECCPS), Universities of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig-University Giessen, German Center for Lung Research (DZL), Giessen, Germany.
Fibrosis involves abnormal myofibroblast buildup. This review explores how mesenchymal stem cells (MSCs) and MSC-like cells contribute to myofibroblast generation in fibrotic diseases across multiple organs.
Area of Science:
- Regenerative Medicine
- Cell Biology
- Pathology
Background:
- Fibrosis, characterized by myofibroblast accumulation, leads to organ failure and mortality.
- Understanding myofibroblast origins is key for developing anti-fibrotic therapies.
Purpose of the Study:
- To review the role of mesenchymal stem cells (MSCs) and MSC-like cells in myofibroblast generation.
- To explore the cellular origins of myofibroblasts in fibrotic diseases.
Main Methods:
- Review of recent genetic lineage tracing studies.
- Synthesis of findings on MSCs and MSC-like cells in fibrosis.
Main Results:
- Diverse organ-resident perivascular MSC-like cells contribute to myofibroblast generation.
- Bone marrow-derived MSCs are also implicated in myofibroblast development during fibrosis.
Conclusions:
- MSCs and MSC-like cells play a significant role in myofibroblast-mediated fibrotic diseases.
- Targeting these cellular sources may offer novel anti-fibrotic treatment strategies.
More Related Videos
Related Concept Videos
Mesenchymal Stem Cells
Satellite Stem Cells and Muscular Dystrophy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Tissue Renewal without Stem Cells
However, failure of such a system...


